Help for your eyes this allergy season
Eye allergies (called allergic conjunctivitis) occur when the eyes react to matter that irritates them, called an allergen, and produce a substance called histamine to fight off the allergen. In New England this time of year, pollen is the most common type of allergen causing eye irritation. But you could also suffer from chronic perennial…
Read MoreMask policy update – April 3, 2024
OCB employees are no longer required to wear masks during direct contact with patients. Patients and visitors do not have to wear a mask unless they become symptomatic. This policy change is due to a decline in rates of respiratory illness over the last several weeks and is in alignment with guidelines issued by Mass…
Read MoreHow to Safely View the April 8 Total Solar Eclipse
There is much excitement building around the solar eclipse that is coming April 8th. Eye doctors at Ophthalmic Consultants of Boston encourage you to enjoy the spectacle, but do so safely, bearing in mind that eye safety is paramount. The total solar eclipse will move across North America during the afternoon of April 8th, tracking…
Read MoreCongratulations Boston Magazine Top Doctors 2024!
OCB is proud of our physicians that were named Castle-Connolly Top Doctors and acknowledged as Boston Magazine Top Doctors 2024! Congratulations to Husam Ansari, MD, Ann Bajart, MD, Mark Dacey, MD, Nicoletta Fynn Thompson, MD, Jeffrey Heier, MD, Ambika Hoguet, MD, James Hung, MD, Jody Judge, MD, Michael Raizman, MD, Peter Rapoza, MD, Claudia Richter, MD, and Torsten Wiegand, MD OCB prides itself on recruiting only the best eye care physicians,…
Read MoreDr. Hoguet coauthors study published in Ophthalmology on SLT laser for glaucoma
OCB congratulates glaucoma specialist Ambika Hoguet, MD, who coauthored an American Academy of Ophthalmology paper assessing the effectiveness of SFT laser in the treatment of glaucoma. The article was published in January 2024 issue of the journal Ophthalmology. Among the study’s conclusions were that SLT is an effective method with minimal safety concerns for IOP control…
Read MoreResearch is advancing treatment options for patients with severe uveitis
Uveitis specialist Lana Rifkin, MD, presented results from the TRS4 Vision trial at the 26th annual American Uveitis Society Winter Symposium in Park City, Utah. The trial evaluated the safety and efficacy of TRS01 eye drops in the treatment of active non-infectious anterior uveitis, a potentially blinding autoimmune eye inflammation, considered the third leading cause of blindness…
Read MoreCelebrating the life of a legendary physician
At an event held this past fall, Dr. Laura Fine and Dr. James Hung unveiled a portrait of the late A. Robert Bellows, MD, in the Boston office, to celebrate the tremendous impact Dr. Bellows had on OCB and the field of ophthalmology. OCB colleagues, including OCB Founder Dr. Albert Frederick, and family members gathered…
Read MoreMasking Update at Ophthalmic Consultants of Boston
Ophthalmic Consultants of Boston’s (OCBs) clinics starting January 8, 2024 will be implementing the below masking changes due to the recent high level of virus activity. This is in alignment with policy changes put in place recently by other local healthcare organizations within our network. These changes are to protect our staff, patients, and visitors:…
Read MoreOCB physicians present at NEOS, Retina Society and AAO national conferences.
OCB eye doctor are leaders in their respective specialties. Throughout the year, they present their research and provide education that advances eye care and it has been a busy Fall. In early October, OCB doctors and clinical staff presented at the New England Ophthalmological Society’s (NEOS) annual meeting that included sessions for physicians and sessions for allied…
Read More